QIAGEN N.V.
QGEN
$47.39
$0.671.43%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.37% | 2.36% | 5.46% | 0.30% | -5.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.37% | 2.36% | 5.46% | 0.30% | -5.48% |
| Cost of Revenue | 6.30% | -3.35% | 5.79% | 167.87% | -6.28% |
| Gross Profit | 4.92% | 5.41% | 5.29% | -84.77% | -5.08% |
| SG&A Expenses | -0.54% | -2.91% | 0.39% | -1.52% | -6.02% |
| Depreciation & Amortization | -18.73% | -18.23% | -14.31% | -4.50% | 0.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.63% | -2.82% | 1.02% | 72.44% | -5.83% |
| Operating Income | 27.40% | 18.92% | 20.73% | -240.62% | -4.17% |
| Income Before Tax | 16.87% | 5.87% | 16.65% | -318.39% | -5.97% |
| Income Tax Expenses | 33.19% | 76.93% | -16.41% | -285.75% | -8.99% |
| Earnings from Continuing Operations | 12.50% | -9.57% | 26.01% | -327.09% | -5.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.50% | -9.57% | 26.01% | -327.09% | -5.13% |
| EBIT | 27.40% | 18.92% | 20.73% | -240.62% | -4.17% |
| EBITDA | 10.81% | 9.71% | 13.72% | -164.76% | -1.30% |
| EPS Basic | 12.11% | -9.74% | 25.50% | -326.36% | -6.32% |
| Normalized Basic EPS | 24.46% | 14.51% | 21.29% | -239.63% | -9.00% |
| EPS Diluted | 10.72% | -9.77% | 25.55% | -330.05% | -5.63% |
| Normalized Diluted EPS | 24.97% | 14.51% | 21.60% | -241.08% | -9.02% |
| Average Basic Shares Outstanding | 0.35% | 0.19% | 0.41% | 0.30% | 1.26% |
| Average Diluted Shares Outstanding | -0.04% | 0.19% | 0.15% | -0.72% | 1.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |